Filing Details

Accession Number:
0001246360-15-001055
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-20 15:56:09
Reporting Period:
2015-02-18
Filing Date:
2015-02-20
Accepted Time:
2015-02-20 15:56:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613103 Medtronic Plc MDT Electromedical & Electrotherapeutic Apparatus (3845) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1379946 J Christopher Oconnell 710 Medtronic Pkwy Ms Lc300
Minneapolis MN 55432
Evp & Grouppres Restora Therap No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-02-18 18,723 $36.24 113,844 No 4 M Direct
Ordinary Shares Disposition 2015-02-18 20,570 $78.28 93,274 No 4 S Direct
Ordinary Shares Acquisiton 2015-02-19 14,390 $36.24 107,664 No 4 M Direct
Ordinary Shares Acquisiton 2015-02-19 15,401 $48.70 123,065 No 4 M Direct
Ordinary Shares Disposition 2015-02-19 29,791 $78.17 93,274 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option (right to buy) Disposition 2015-02-18 18,723 $0.00 18,723 $36.24
Ordinary Shares Employee Stock Option (right to buy) Disposition 2015-02-19 14,390 $0.00 14,390 $36.24
Ordinary Shares Employee Stock Option (right to buy) Disposition 2015-02-19 15,401 $0.00 15,401 $48.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,390 2009-10-27 2018-10-27 No 4 M Direct
0 2009-10-27 2018-10-27 No 4 M Direct
0 2007-10-30 2016-10-30 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 2,654 Indirect ESOP
Footnotes
  1. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.145 to $78.42, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 to $78.50, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.